Both in Pharmaceuticals
Vyome Holdings vs Cellectar Biosciences INC NEW
Over the past year HIND returned −71.5% and CLRB returned −63.5%; their daily moves had a correlation of 0.22.
HIND −71.5% CLRB −63.5%Growth of $1, one year, split-adjusted
| Metric | HIND | CLRB |
|---|---|---|
| Price | $1.80 | $1.21 |
| Market cap | $12.6M | $11.4M |
| Today | +2.86% | −1.23% |
| 1 month | −6.3% | −35.6% |
| 6 months | −8.2% | −55.2% |
| Year to date | −47.7% | −59.2% |
| 1 year | −66.5% | −64.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 43.2% | — |
| Net margin | −2543.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 97.4× | — |
| Net cash | $7.9M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 41.5% | 66.3% |
| Short % of float | 1.2% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).